Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T16:03:50.341Z.
Calculation as of: 2026-10-06T16:03:50.341Z.
Quote observation: 2026-10-06T15:57:12.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e1439c3a9e54fb1f97ae208c5489c534aa692153c8f3b45d8dac24981f451ae3
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Market Cap
$22.65M
Free Cash Flow Yield
14.36%
TTM Avg
7.57%
3Y Avg
26.94%
5Y Avg
26.94%
Market Cap
$22.78M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$21.60M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$20.73M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$23.96M
Free Cash Flow Yield
N/A
TTM Avg
2.30%
3Y Avg
2.29%
5Y Avg
1.98%
Market Cap
$20.09M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$24.74M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$19.66M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LeonaBio, Inc. (LONA) | $22.28M | N/A | N/A | N/A | N/A |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.65M | 14.36% | 7.57% | 26.94% | 26.94% |
| Rein Therapeutics Inc. (RNTX)vs › | $22.78M | N/A | N/A | N/A | N/A |
| Modular Medical, Inc. (MODD)vs › | $21.60M | N/A | N/A | N/A | N/A |
| Quantum BioPharma Ltd. (QNTM)vs › | $20.73M | N/A | N/A | N/A | N/A |
| Kyntra Bio, Inc. (KYNB)vs › | $23.96M | N/A | 2.30% | 2.29% | 1.98% |
| Actuate Therapeutics Inc (ACTU)vs › | $20.09M | N/A | N/A | N/A | N/A |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.74M | N/A | N/A | N/A | N/A |
| P3 Health Partners Inc. (PIII)vs › | $19.66M | N/A | N/A | N/A | N/A |
| ABVC BioPharma, Inc. (ABVC)vs › | $24.96M | N/A | 104.34% | 104.34% | 104.34% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
